Search for Stocks /

Borosil Scientific Ltd Q3 FY26: ₹121 Cr Sales, ₹8.7 Cr PAT, 132% Profit Jump — Is India’s Lab King Finally Heating Up?


1. At a Glance – The Beaker Is Boiling 🧪🔥

Market Cap: ₹1,057 Cr
Current Price: ₹119
Stock P/E: 44.4
ROCE: 10.3%
ROE: 6.87%
Debt: ₹8.86 Cr (almost zero, chai peene jitna)
Q3 FY26 Sales: ₹121 Cr (up 19.6% YoY)
Q3 FY26 PAT: ₹8.7 Cr (up 132% YoY)

Borosil Scientific just served a quarter where profits jumped 132% YoY. Yes, 132%. The same company that was looking sleepy a few quarters ago suddenly said, “Beta, lab test positive hai.”

Sales hit ₹121 Cr in Q3 FY26, margins expanded to 14.17% OPM, and the company is riding the Make in India + China Plus One wave.

But hold your pipettes. The stock trades at 44x earnings, above industry median 40x. The market is already pricing in some serious scientific optimism.

So the big question: Is this a structural growth story or just a good quarter with lab lighting and background music?

Let’s open the microscope.


2. Introduction – From Test Tubes to Trade Tensions

Borosil isn’t new. Since 1962, this brand has basically been the default choice in Indian labs. If you studied chemistry in India, chances are you broke at least one Borosil beaker.

In FY24, the scientific division got demerged from Borosil Ltd and listed separately in June 2024. So technically, this is a relatively fresh listed entity, but with a 60+ year legacy.

Now here’s the spicy part.

India is pushing manufacturing. Pharma exports are growing. Labs are expanding. Environmental testing is becoming mandatory. Government research institutes are spending more.

And Borosil is sitting right in the center of this ecosystem.

Segment mix Q1 FY25:

  • Scientific Segment: 65%
  • Glassware Segment: 35%

Customer mix:

  • Pharma: 61%
  • Government Research: 14%
  • Universities: 13%

In short, if Indian science grows, Borosil grows.

But here’s what makes it interesting: they’re no longer just selling glass bottles. They’re pushing lab equipment, process systems, pharma packaging — higher margin stuff.

Are we looking at a labware company evolving into a full-stack scientific solutions business?

Or is it still just a glorified beaker manufacturer?

Let’s decode.


3. Business Model – WTF Do They Even Do?

Okay, imagine you are starting a pharma lab in India.

What do you need?

  • Glassware (beakers, flasks, bottles)
  • Instruments (stirrers, nitrogen systems)
  • Process reactors
  • Ampoules and vials for injectables
  • Calibration services

Now imagine buying

Read Full 16 Point breakdown. Continue reading →
Members get full access to every article.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →